Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Diseases

Explore clinical trials studying Urinary Bladder Diseases. Study availability and eligibility vary by location and protocol.

2,338 public trials 427 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Diseases trial results

Recruiting

A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer

NCT06503614

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Weill Cornell Medical Center New York, United States
View Trial Details
Recruiting

Akyva First In Human

NCT06956209

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations
  • Princess Alexandra Hospital Woolloongabba, Queensland, Australia
  • Australian Prostate Centre Melbourne N., Victoria, Australia
View Trial Details
Recruiting

Aquarius Pilot Study to Evaluate the New Axonics Trial System

NCT07335484

Conditions
Digestive System Diseases, Fecal Incontinence, Fecal Incontinence (FI), +20 more
Locations
  • Calvary North Adelaide Hospital/Better Bladders North Adelaide, South Australia, Australia
  • Epworth Freemasons Hospital East Melbourne, Victoria, Australia
  • Southern Urogynecology West Columbia, South Carolina, United States
View Trial Details
Recruiting

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

NCT05059444

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Carcinoma, +82 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • University of California, San Diego La Jolla, California, United States
View all 57 locations
View Trial Details
Recruiting

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

NCT06833073

Conditions
Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +13 more
Locations
  • Michael G Oefelein Clinical Trials ( Site 0138) Bakersfield, California, United States
  • Genesis Research, LLC ( Site 0141) Los Alamitos, California, United States
  • USC Norris Comprehensive Cancer Center ( Site 0123) Los Angeles, California, United States
  • Genesis Healthcare-Torrance ( Site 0140) Torrance, California, United States
View all 89 locations
View Trial Details
Recruiting

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

NCT06511141

Conditions
Benign Prostatic Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +23 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Urology Associates Fairhope, Alabama, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Tri Valley Urology Murrieta, California, United States
View all 23 locations
View Trial Details
Recruiting

PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB

NCT06789406

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +14 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • University of Missouri Columbia, Missouri, United States
  • Bradford Royal Infirmary Bradford, West Yorkshire, United Kingdom
  • Pinderfields Hospital Wakefield, West Yorkshire, United Kingdom
View Trial Details
Recruiting

A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)

NCT07222488

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Michael G Oefelein Clinical Trials ( Site 0005) Bakersfield, California, United States
  • Carolina Urologic Research Center ( Site 0006) Myrtle Beach, South Carolina, United States
  • Medizinische Universität Wien ( Site 0021) Vienna, State of Vienna, Austria
  • UZ Gent ( Site 0031) Ghent, Oost-Vlaanderen, Belgium
View all 17 locations
View Trial Details

Related conditions